home *** CD-ROM | disk | FTP | other *** search
- <text id=93TT0143>
- <title>
- July 12, 1993: A Growing Controversy
- </title>
- <history>
- TIME--The Weekly Newsmagazine--1993
- July 12, 1993 Reno:The Real Thing
- </history>
- <article>
- <source>Time Magazine</source>
- <hdr>
- MEDICINE, Page 49
- A Growing Controversy
- </hdr>
- <body>
- <p>Should researchers stop a study that gives healthy kids a drug
- to make them taller?
- </p>
- <p> Short kids don't have it easy. They are pitied by playmates
- and picked on by bullies. More worrisome to some parents, short
- kids often grow up into short adults. Today many unhappy youngsters
- and their families have their hopes pinned on what is being
- touted as a medical fix to the problem: injections of a synthetic
- version of human growth hormone (HGH). But efforts to test the
- drug have exploded into a medical and ethical controversy. The
- chief issue: Can an experiment that gives healthy children a
- drug simply to change their looks be justified?
- </p>
- <p> The debate flared anew last week when two organizations--the
- Physicians Committee for Responsible Medicine and the Foundation
- on Economic Trends--filed suit to halt a National Institutes
- of Health study that would give HGH to 80 boys and girls. The
- youngsters' pituitary glands produce typical amounts of HGH,
- and the children are within the normal height range for their
- ages of nine to 15, but they are shorter than average. The study
- had been suspended a year ago after the two groups accused the
- agency of violating federal regulations governing research with
- healthy children, but was resumed recently following a recommendation
- from an NIH advisory panel.
- </p>
- <p> Federal rules require that research pose only a minimal potential
- risk to youngsters and glean important information about a medical
- condition. The study doesn't qualify, the groups charge. They
- claim that HGH therapy may increase the chance of developing
- cancer. Moreover, shortness is not a medical condition but a
- social problem. "There's no physical risk to being short," declares
- Dr. Neal Barnard of the Physicians Committee. Adds the foundation's
- Jeremy Rifkin: "NIH can't experiment on healthy kids if there's
- no medical problem."
- </p>
- <p> NIH's independent advisory panel concluded otherwise. One reason
- offered for pressing forward with the study is that as many
- as 10,000 healthy youngsters have already been treated with
- HGH by physicians, despite lack of information about its long-term
- safety or efficacy. While the panel concedes that being short
- is not a medical disorder, it can make some things harder to
- do, like driving a car, and cause psychological problems. "There
- is heightism in our society," says panel member Dr. Melvin Grumbach
- of the University of California at San Francisco. NIH estimates
- that 100,000 U.S. children could receive HGH if it proves effective.
- </p>
- <p> That possibility infu riates critics, who argue that the healthier
- approach would be to take the stigma out of being short. Instead,
- says Barnard, the NIH is legitimizing bias by implicitly "telling
- kids they're not adequate as they are."
- </p>
- <p>-- By Anastasia Toufexis. Reported by Ellen Germain/Washington
- and Alice Park/New York
- </p>
-
- </body>
- </article>
- </text>
-
-